Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fitscha

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
American Journal of Hematology|May 1, 1985
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular diseaseP Fitscha, J Kaliman, H Sinzinger
Progress in Clinical and Biological Research|January 1, 1987
Iloprost in peripheral vascular disease--platelet function and clinical outcomeP Fitscha, B Tiso, H Sinzinger
Postgraduate Medical Journal|April 1, 1987
Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivoH Sinzinger, J O'Grady, P Fitscha
Prostaglandins, Leukotrienes, and Medicine|September 1, 1982
Hypertension and beneficial treatment with beta-blocking agents does not change the platelet sensitivity to the antiaggregatory prostaglandinsH Sinzinger, P Fitscha, J Kaliman
European Journal of Clinical Pharmacology|January 1, 1990
Comparison of bopindolol and atenolol in chronic stable angina pectorisP Fitscha, W Meisner, B Tiso
Thrombosis Research|February 15, 1990
Platelet kinetics in patients with atherosclerosisH Sinzinger, I Virgolini, P Fitscha
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|December 1, 1994
Synergistic antiplatelet action of nitric oxide (NO) with PGD2 and its metabolite PGJ2--relevance for cerebral circulation?M Rodrigues, P Fitscha, H Sinzinger
Wiener Klinische Wochenschrift|January 23, 1981
[Contribution of long-term ECG monitoring in analysing cardiac arrhythmias (author's transl)]P Fitscha, B Tiso, W Meisner
Wiener Klinische Wochenschrift|January 20, 1984
[Long-term ECG in clinical practice]B Tiso, P Fitscha, W Meisner
Agents and Actions. Supplements|January 1, 1997
Antimitotic actions of vasodilatory prostaglandins--clinical aspectsH Sinzinger, P Fitscha, H Kritz
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
American Journal of Hematology|May 1, 1985
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular diseaseP Fitscha, J Kaliman, H Sinzinger
Progress in Clinical and Biological Research|January 1, 1987
Iloprost in peripheral vascular disease--platelet function and clinical outcomeP Fitscha, B Tiso, H Sinzinger
Postgraduate Medical Journal|April 1, 1987
Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivoH Sinzinger, J O'Grady, P Fitscha
Prostaglandins, Leukotrienes, and Medicine|September 1, 1982
Hypertension and beneficial treatment with beta-blocking agents does not change the platelet sensitivity to the antiaggregatory prostaglandinsH Sinzinger, P Fitscha, J Kaliman
European Journal of Clinical Pharmacology|January 1, 1990
Comparison of bopindolol and atenolol in chronic stable angina pectorisP Fitscha, W Meisner, B Tiso
Thrombosis Research|February 15, 1990
Platelet kinetics in patients with atherosclerosisH Sinzinger, I Virgolini, P Fitscha
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|December 1, 1994
Synergistic antiplatelet action of nitric oxide (NO) with PGD2 and its metabolite PGJ2--relevance for cerebral circulation?M Rodrigues, P Fitscha, H Sinzinger
Wiener Klinische Wochenschrift|January 23, 1981
[Contribution of long-term ECG monitoring in analysing cardiac arrhythmias (author's transl)]P Fitscha, B Tiso, W Meisner
Wiener Klinische Wochenschrift|January 20, 1984
[Long-term ECG in clinical practice]B Tiso, P Fitscha, W Meisner
Agents and Actions. Supplements|January 1, 1997
Antimitotic actions of vasodilatory prostaglandins--clinical aspectsH Sinzinger, P Fitscha, H Kritz
Pageof 13